Purification and properties of the hexosaminidase A-activating protein from human liver.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 1183716)

Published in Biochem J on December 01, 1977

Authors

P Hechtman, D LeBlanc

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99

DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96

A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem (1961) 59.20

Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J (1964) 35.63

Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature (1962) 20.19

Glycoprotein staining following electrophoresis on acrylamide gels. Anal Biochem (1969) 12.65

CHROMATOGRAPHIC SEPARATION OF HUMAN BRAIN GANGLIOSIDES. J Neurochem (1963) 6.22

Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J (1961) 4.71

Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci U S A (1971) 2.53

[Enrichment and characterization of 2 forms of human N-acetyl-beta-D-hexosaminidase]. Hoppe Seylers Z Physiol Chem (1971) 1.45

Absence of hexosaminidase A and B in a normal adult. N Engl J Med (1975) 1.43

The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. Hoppe Seylers Z Physiol Chem (1975) 1.26

Juvenile GM2 gangliosidosis: partial deficiency of hexosaminidase A. J Pediatr (1970) 1.23

An activator stimulating the enzymic hydrolysis of sphingoglycolipids. J Biol Chem (1976) 1.22

Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts. Clin Genet (1977) 1.21

Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine. J Biol Chem (1973) 1.20

Glucocerebrosidase: reconstitution of activity from macromolecular components. Biochem J (1973) 1.17

PHYSICOCHEMICAL PROPERTIES OF OX-BRAIN GANGLIOSIDES. Biochem J (1963) 1.15

The hydrolysis of Tay-Sachs ganglioside (TSG) by human N-acetyl-beta-D-hexosaminidase A. FEBS Lett (1970) 1.12

Effect of bile salts on lactosylceramide beta-galactosidase activities in human brain, liver and cultured skin fibroblasts. Biochim Biophys Acta (1975) 1.01

Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver. Carbohydr Res (1974) 1.00

Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A. Can J Biochem (1977) 0.99

Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates. J Biol Chem (1975) 0.97

Conversion of human hexosaminidase A to hexosaminidase "B" by crude Vibrio cholerae neuraminidase preparations: merthiolate is the active factor. Biochim Biophys Acta (1974) 0.97

Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts. Am J Hum Genet (1976) 0.96

Glucocerebrosidase: stoichiometry of association between effector and catalytic proteins. Biochim Biophys Acta (1975) 0.95

Enzymatic hydrolysis of sphingolipids. VI. Hydrolysis of ceramide glycosides by calf brain beta-N-acetylhexosaminidase. Biochemistry (1967) 0.89

The catabolism of Tay-Sachs ganglioside in rat brain lysosomes. J Biol Chem (1972) 0.86

Microheterogeneity of N-acetyl- -D-hexosaminidase of bull epididymis. Proc Soc Exp Biol Med (1973) 0.80

Articles by these authors

Incidence of cleft palate fistula: an institutional experience with two-stage palatal repair. Plast Reconstr Surg (2001) 1.59

Pathogenicity of Eikenella corrodens in humans. Arch Intern Med (1983) 1.42

Cytotoxicity of carbobenzoxy-protected amino acids. In Vitro Cell Dev Biol (1992) 1.41

Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis (1975) 1.35

Treating hypertension. Are the right drugs given to the right patients? Can Fam Physician (1998) 1.35

Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. Clin Chim Acta (1984) 1.27

Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB. Pediatr Res (1982) 1.15

A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. Hum Mol Genet (1992) 1.02

Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A. Can J Biochem (1977) 0.99

Cloning, sequencing, and expression in Escherichia coli of the D-hydantoinase gene from Pseudomonas putida and distribution of homologous genes in other microorganisms. Appl Environ Microbiol (1994) 0.94

Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews. Genet Epidemiol (1992) 0.94

Prolidase deficiency: a multisystemic hereditary disorder. J Am Acad Dermatol (1993) 0.93

Identification of candidate active site residues in lysosomal beta-hexosaminidase A. J Biol Chem (1997) 0.93

A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease. Am J Hum Genet (1987) 0.93

Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients. Am J Hum Genet (1987) 0.90

The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders. Hum Genet (1992) 0.89

Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin Nephrol (1988) 0.89

Expression and molecular analysis of mutations in prolidase deficiency. Am J Hum Genet (1996) 0.88

Tay-Sachs disease: B1 variant. Pediatr Neurol (1989) 0.88

Importance of neutralizers in the stripping fluid in a simulated healthcare personnel handwash. Infect Control Hosp Epidemiol (1990) 0.88

Apparent hexosaminidase B deficiency in two healthy members of a pedigree. Am J Hum Genet (1979) 0.87

Four novel PEPD alleles causing prolidase deficiency. Am J Hum Genet (1994) 0.87

Purification and properties of two enzymes catalyzing galactose transfer to GM2 ganglioside from rat liver Golgi. J Biol Chem (1983) 0.87

The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease. Am J Hum Genet (1996) 0.87

Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside. Biochem J (1980) 0.84

Metachromatic leukodystrophy: multiple nonfunctional and pseudodeficiency alleles in a pedigree: problems with diagnosis and counseling. Ann Neurol (1993) 0.82

Neutral amino acid transport in Pseudomonas fluorescens. J Bacteriol (1970) 0.82

A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts. Clin Genet (1983) 0.81

Red blood cell carbonic anhydrase activity in children with distal renal tubular acidosis. Pediatr Res (1977) 0.81

The effects of surfactant systems and moisturizing products on the residual activity of a chlorhexidine gluconate handwash using a pigskin substrate. Infect Control Hosp Epidemiol (1990) 0.81

Human genetics of membrane transport with emphasis on amino acids. Adv Hum Genet (1970) 0.80

Allele-specific amplification of genomic DNA for detection of deletion mutations: identification of a French-Canadian Tay-Sachs mutation. J Inherit Metab Dis (1991) 0.80

Gamma-aminobutyric acid metabolism in brain homogenates of the spastic mouse. Biochem Genet (1977) 0.80

A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family. Hum Mutat (1992) 0.79

Purification and characterization of activated human erythrocyte prolidase. Biochem Cell Biol (1989) 0.79

A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts. Eur J Hum Genet (1997) 0.79

Isolation and properties of a beta-alanine transaminaseless mutant of Pseudomonas fluorescens. J Bacteriol (1970) 0.78

The isolation and properties of a beta-alanine permeaseless mutant of Pseudomonas fluorescens. Biochim Biophys Acta (1970) 0.78

Lymphocytotoxic antibodies to non-HLA antigens in the sera of patients with acquired immunodeficiency syndrome (AIDS). Prog Clin Biol Res (1983) 0.78

Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A. Biochim Biophys Acta (1997) 0.77

Novel Tay-Sachs disease mutations from China. Hum Mutat (1992) 0.77

Rat liver Golgi galactosyltransferases. Distinct enzymes for glycolipid and glycoprotein acceptor substrates. Biochem J (1984) 0.75

L-Triiodothyronine aminotransferase. J Biol Chem (1973) 0.75

Reduction of unsafe eating in a patient with esophageal stricture. J Appl Behav Anal (1999) 0.75

Variable onset of metachromatic leukodystrophy in a Vietnamese family. Pediatr Neurol (2000) 0.75

Comments on the use of cord-blood mononuclear cells in screening for DR specific maternal antibodies. Tissue Antigens (1983) 0.75

A Pst+ polymorphism in the HEXA gene with an unusual geographic distribution. Eur J Hum Genet (1993) 0.75

The GM2 gangliosidoses databases: allelic variation at the HEXA, HEXB, and GM2A gene loci. Genet Med (2001) 0.75

High-capacity method for purification of human liver hexosaminidase B using hydrophobic chromatography. J Chromatogr (1980) 0.75

[First experiences in psychiatric nursing]. Infirm Can (1966) 0.75

Genetic control of ganglioside biosynthesis in mice. Biochem Genet (1988) 0.75

Diagnosis of Tay-Sachs disease on blood obtained at fetoscopy. Lancet (1979) 0.75

First experiences in psychiatric nursing. Can Nurse (1966) 0.75

A chicken sex-limited protein that crossreacts with the fourth component of complement. Poult Sci (1987) 0.75

Prolidase deficiency in cultured human fibroblasts: biochemical pathology and iminodipeptide-enhanced growth. Pediatr Res (1992) 0.75

HLA typing of amniotic fluid cells for the prenatal determination of therapeutic transplantation options for a fetus affected with adenosine deaminase deficiency. Transplantation (1983) 0.75

Substrate binding properties of the human liver hexosaminidase A activator protein. Can J Biochem Cell Biol (1985) 0.75

Effects of lidocaine on the lysosomes of cultured skin fibroblasts. Cell Biol Int Rep (1982) 0.75

A soluble 3,5-dinitrotyrosine aminotransferase from rabbit liver which catalyzes the transamination of thyroid hormone. Biochem Biophys Res Commun (1971) 0.75

Interspecific and intraspecific variation in proximate, mineral, and fatty acid composition of milk in Old World fruit bats (Chiroptera: Pteropodidae). Physiol Biochem Zool (2001) 0.75